Univariate correlation and linear regression analyses suggest that the main determinants of the decrease of atherosclerosis development by d-[113–122]apoJ administration were the HDL susceptibility to oxidation and LDL electronegativity. This evidence concerns the gene CLU and atherosclerosis.